Astrazeneca Plc ADR (AZN) Recent Earnings
Astrazeneca Plc ADR (AZN) reported 2nd Quarter June 2021 earnings of $0.45 per share on revenue of $8.2 billion. The consensus earnings estimate was $0.45 per share on revenue of $7.4 billion. Revenue grew 31.0% on a year-over-year basis.
AstraZeneca PLC is a biopharmaceutical company. It is engaged in the
discovery and development of new products, which are then manufactured,
marketed and sold.